Events

Medicon Valley Alliance together with Lund Stem Cell Center, Lund University have the pleasure to invite you the Medicon Valley Alliance R&D Network meeting on 24th of November, 2021 in Lund. Cell and gene therapies are being widely accepted as one of the most transformative innovative trends in biopharmaceuticals. Cell and gene therapies are expected […]

Join us for this live webinar to learn about Molecular Classification-based identification of diagnostic and treatment targets in glioma. Dr. Xiaolong Fan, professor at Beijing Normal University in China will provide a high-level overview of his experience in dealing with the challenges of this project. His team has been pursuing this project for about 15 […]

HealthTech @ Medicon Valley 2021: Commercialisation in Europe Wednesday the 17th of November 8.30 – 13.00 A side event to TechConnect Europe 2021 The Nordics and Medicon Valley feature world-class healthcare and research institutions, highly skilled hardware and software expertise, a thriving game industry and a strong startup scene. To showcase our regional life science, […]

Both Denmark and Sweden, having launched new national life science strategies, have clearly made life science a national strategic priority. But what is the potential for future Danish-Swedish life science collaboration post the COVID-19 pandemic? Where are the synergies, and how do we leverage them for the benefit of science, industry, healthcare and patients alike? […]

With the increasing emphasis on precision medicine, most discussion of diabetes has focused on heterogeneity in type 2 diabetes and distinguishing T2D from monogenic diabetes or atypical forms of diabetes, with the assumption that one can accurately define T1D based on the clinical phenotype. However, this view has been substantially altered by two major changes: […]

The ISO 13485 sets out the requirements for a quality management system specific to the medical devices industry. Why should you have a QMS in the first place, and why use the ISO 13485 standard? We’ll share hands-on experience on what the standard means in practice, as well as ideas on how you can ensure […]

Sino Biological presents: A Comprehensive Overview of the CRO Service Platform Sino Biological is dedicated in providing the scientific community with high-quality recombinant protein and antibody reagents to promote life science research and drug discovery. Several robust recombinant protein expression platforms and antibody discovery methods have been established and are available for customized contracted research […]

Find out about new research related to COVID-19 and the impact on male reproductive function – now and in the future. Organised by ReproUnion where MVA is a partner alongside Region Skåne, Region H, Ferring and the universities in Copenhagen, Lund and Malmö.

– tackling two of the most intensely regulated pathways in one go   Combination products are a fast developing market but a tricky one. Yet this market is really picking up speed. New technologies enable patient care in ever improving levels. But how do you tackle two of the most intensely regulated pathways in one […]

Starting with an overview of beyond rule of five (bRo5) drugs and the key challenges behind these drugs, in this webinar, experts will discuss how intracellular concentrations of drugs is influenced by drug-transporting proteins and metabolizing enzymes and how they are involved in delivering effective drug as well as determining toxicity and drug interactions. The […]

Medical device companies endeavour to connect their innovative products, to enable collaboration with patients. While they understand the importance of data to enhance personalized remote patient monitoring and ensure the continuum of care they can’t afford investing in complex and timely projects and implementation. In this webinar you will learn: How to successfully develop and […]

Medicon Valley Alliance have the pleasure to invite you to the 11th meeting within the Medtech Network. The meeting will be hosted by MVA member company Key2Compliance and will focus on Clinical trials in Medtech.  We are looking forward to host a physical event in Copenhagen with insightful presentations followed by networking. The medical device […]

Opportunities in finance, investments and precision medicine Welcome to the 10th edition of our international partnering event The Future of Swedish & Danish Life Science. This years themes are: Reflections on the past decade, and looking to the future Investments and finance Precision medicine Date: 2nd September 2021 Venue: Medicon Village, Lund, Sweden The event […]

Welcome to the 9th edition of New updates in Drug Formulation & Bioavailability. This event is a platform based on the concept of synergies between “science” and “business”. Meet R&D people, the pharma industry, increase your awareness and gain more knowledge about this exciting topic. The presented content and topics will focus on advancements in […]

Drug development in oncology is undergoing several changes brought about by precision medicine, which makes it appealing to move efficacy assessment to earlier-phase trials and questions the need for randomized trials. Indeed, some remarkably efficacious drugs have even been approved based on uncontrolled phase I or II trials. With very few exceptions, we challenge the […]

Medicon Valley Alliance together with member company Ascelia Pharma have the pleasure to invite you to the 11th meeting of the Medicon Valley Alliance Oncology Network on the 24th of August, 2021. Rare disease affects a small number of patients; the European Medicines Agency defines rare disease where the prevalence of the disease is less […]

Join us for the live streaming from the presentation of the new analysis Life Science Across the Øresund The new analysis Life science across the Øresund will be presented during live streaming on 22nd of June 2021. The analysis will show the comprehensive collaboration across Øresund with regards to commuting, workforce, investments, businesses and research. […]

Introducing the new single-use separator, Alfa Laval CultureOne™ From greater flexibility to shorten the time to market, to increased assurance of patient safety, several factors have driven the growing transition to single-use processing in the biopharma industry. More manufacturers are seeking solutions that enable smaller batches and predictable, scalable production. Of course, this requires compact […]

Implementing and Validating Meso Scale Discovery – ECL Detection for Clinical Trials When implementing biomarker strategies for clinical trials, it is not only important to choose the right analysis platform but also have the assays validated and performed to meet regulatory submission requirements. Unilabs Serving Pharma group, in collaboration with Meso-Scale Discovery (MSD) will present […]

A well-functioning research infrastructure is a key fundamental to support science and to accelerate innovation within academia and industry. Researchers and individual companies requires access to complex technologies and often lack some of the expertise required in-house to address all aspects of complex research questions. Many national, regional and private initiatives have invested in significant […]

Discovering and characterizing novel drug candidates for preclinical development depends on innovative and reliable science. Charles River’s unique combination of integrated, multidisciplinary drug discovery expertise and unparalleled scope of capabilities in targets, platforms, and therapeutic areas allow us to deliver depth and breadth in science with data and insight you can trust to progress your […]

The success of several drugs in amorphous systems in the commercial market confirm that amorphous drug delivery system is one the efficient ways of enhancing solubility and optimizing bioavailability of poorly soluble drugs. Spray drying and hot melt extrusion are the two technologies most widely used for the preparation of amorphous solid dispersion. In addition, […]

Keep up with transparency trends and leverage disclosure data for patient engagement and recruitment While the complexity and costs of clinical trial transparency regulations continue to increase, there are growing opportunities to leverage investments in disclosure compliance. Understanding the requirements and trends helps identify opportunities to reuse the disclosure data beyond submissions to regulatory authorities […]

The 7 most important things to update in your technical documentation and your QMS, and how they interact Do you want to understand which parts of the MDR that you as medical device manufacturer must have in place on May 26th and what you need to adjust in your technical documentation, when CE-marking a device […]

Join the Greater Copenhagen Microbiome Summit for the latest scientific trends and insights within the microbiome field from companies like BioGaia, Chr. Hansen, Ferring and Novozymes as well as academic experts. The Greater Copenhagen Microbiome Summit offers a digital venue for bringing together microbiome scientists and companies to define the state of microbiome research and […]